Target
Cyclin-dependent kinase 4
Ligand
BDBM146970
Substrate
n/a
Meas. Tech.
Biological Assay
pH
7.5±n/a
Temperature
295.15±n/a K
IC50
<4±n/a nM
Comments
extracted
Citation
 Brain, CTCho, YSGiraldes, JWLagu, BLevell, JRLuzzio, MJPerez, LBWang, YYang, F Pyrrolopyrimidine compounds as inhibitors of CDK4/6 US Patent  US8957074 Publication Date 2/17/2015 
Target
Name:
Cyclin-dependent kinase 4
Synonyms:
CDK4 | CDK4_HUMAN | Cell division protein kinase 4 | Cyclin-dependent kinase 4 (CDK 4) | PSK-J3
Type:
Enzyme Subunit
Mol. Mass.:
33731.96
Organism:
Homo sapiens (Human)
Description:
P11802
Residue:
303
Sequence:
MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNPE
  
Inhibitor
Name:
BDBM146970
Synonyms:
US8957074, 9
Type:
Small organic molecule
Emp. Form.:
C26H32N8O2
Mol. Mass.:
488.5847
SMILES:
CN(C)C(=O)c1cc2cnc(Nc3ccc(cn3)C(=O)N3CC4CNC(C4)C3)nc2n1C1CCCC1
Structure:
Search PDB for entries with ligand similarity: